Cargando…
Introduction and geographic availability of new antibiotics approved between 1999 and 2014
BACKGROUND: Despite the urgent need for new, effective antibiotics, few antibiotics of value have entered the market during the past decades. Therefore, incentives have been developed to stimulate antibiotic R&D. For these incentives to be effective, geographic availability for recently approved...
Autores principales: | Kållberg, Cecilia, Årdal, Christine, Salvesen Blix, Hege, Klein, Eili, M. Martinez, Elena, Lindbæk, Morten, Outterson, Kevin, Røttingen, John-Arne, Laxminarayan, Ramanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191083/ https://www.ncbi.nlm.nih.gov/pubmed/30325963 http://dx.doi.org/10.1371/journal.pone.0205166 |
Ejemplares similares
-
The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021) -
An antibiotic’s journey from marketing authorization to use, Norway
por: Årdal, Christine, et al.
Publicado: (2017) -
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005
por: Klein, Eili, et al.
Publicado: (2007) -
Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006
por: Klein, Eili, et al.
Publicado: (2009) -
Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001–2015
por: Bollestad, Marianne, et al.
Publicado: (2017)